Investigation of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease

BACKGROUND: Dual antiplatelet therapy (DAPT) is currently the standard treatment for the prevention of ischemic events after stent implantation. However, the optimal DAPT duration remains elusive for patients with chronic kidney disease (CKD). Therefore, we aimed to compare the effectiveness and saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Kao, Chih-Chin, Wu, Mai-Szu, Chuang, Ming-Tsang, Lin, Yi-Cheng, Huang, Chun-Yao, Chang, Wei-Chiao, Chen, Chih-Wei, Chang, Tzu-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336855/
https://www.ncbi.nlm.nih.gov/pubmed/34347826
http://dx.doi.org/10.1371/journal.pone.0255645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336855/
https://www.ncbi.nlm.nih.gov/pubmed/34347826
http://dx.doi.org/10.1371/journal.pone.0255645

Ejemplares similares